Morgan Stanley is betting on these stocks to benefit from the AI megatrend.
AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.
2024 is going to be a sizzler in the biopharma sector.
Its groundbreaking work is winning it some powerful fans, but it's still risky.
There's more to the AI boom than Microsoft and ChatGPT.
Cathie Wood and Bill Gates like this stock, too.
Its future could be bright, but don't get too attached to its successes right now.
/PRNewswire/ -- Qiming Venture Partners' portfolio company Tuhu Car, China's leading one-stop car service platform, successfully listed on the Hong Kong Stock...
None of these stocks have outperformed Nvidia so far this year. But the next 12 months could be a different story.
The high cost of developing drugs makes the use of artificial intelligence a natural fit for pharmaceutical companies.